Please login to the form below

Not currently logged in
Email:
Password:

EvaluatePharma

This page shows the latest EvaluatePharma news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca to acquire Alexion for $39bn

AstraZeneca to acquire Alexion for $39bn

By EvaluatePharma’s forecasts, the global rare disease market is set to grow by a low double digit percentage until 2026.

Latest news

More from news
Approximately 3 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • It started with a miss It started with a miss

    The stakes are high and getting higher. A recent report from EvaluatePharma forecasts that pharma is on the brink of a second patent cliff, with worldwide drug sales of over $198bn

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    EvaluatePharma has predicted it could become a nearly $2.5bn product by 2024, providing it can also pick up approvals in AML and other indications like multiple myeloma.

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    EvaluatePharma forecasts that Lynparza (now co-marketed with Merck &Co) will hit annual revenues of $2.2bn by 2024, with Imfinzi expected to reach $3.65bn and Tagrisso leading the way

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The company is currently the pharma industry’s biggest player by revenue (earning $45.4bn in 2017), but analysts EvaluatePharma expect Novartis to overtake it by 2024.

  • Deal Watch May 2016 Deal Watch May 2016

    A recent analysis through 2015 made by EvaluatePharma shows that six of the top ten pharma companies will derive less than 20% of drug sales from products that were developed from

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics